Mcdonald Partners LLC Eli Lilly & CO Transaction History

Mcdonald Partners LLC

$390 Million
Q3 2024

A detailed history of Mcdonald Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mcdonald Partners LLC holds 1,110 shares of LLY stock, worth $830,291. This represents 0.25% of its overall portfolio holdings.

Number of Shares

1,110

Previous 1,160 4.31%

Holding current value

$830,291

Previous $1.05 Million 6.38%

% of portfolio

0.25%

Previous 0.29%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$772.14 - $960.02 $38,607 - $48,001	-50 Reduced 4.31%	1,110 $983,000
Q2 2024 Jul 17, 2024	SELL	$724.87 - $909.04 $1,449 - $1,818	-2 Reduced 0.17%	1,160 $1.05 Million
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $4,145 - $5,545	7 Added 0.61%	1,162 $903,000
Q3 2023 Oct 30, 2023	BUY	$434.7 - $599.3 $23,908 - $32,961	55 Added 5.0%	1,155 $620,000
Q2 2023 Jul 17, 2023	SELL	$350.74 - $468.98 $8,768 - $11,724	-25 Reduced 2.22%	1,100 $515,000
Q1 2023 Apr 19, 2023	BUY	$310.63 - $364.82 $15,531 - $18,241	50 Added 4.65%	1,125 $386,000
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $14,824 - $16,893	-50 Reduced 4.44%	1,075 $348,000
Q1 2022 Apr 29, 2022	BUY	$234.69 - $291.66 $263,556 - $327,534	1,123 Added 56150.0%	1,125 $322,000
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $723,792 - $898,229	-3,219 Reduced 99.94%	2 $0
Q3 2021 Oct 28, 2021	SELL	$221.6 - $272.71 $11,080 - $13,635	-50 Reduced 1.53%	3,221 $744,000
Q2 2021 Jul 23, 2021	SELL	$180.55 - $233.54 $207,632 - $268,571	-1,150 Reduced 26.01%	3,271 $751,000
Q1 2021 Apr 15, 2021	BUY	$164.32 - $212.72 $726,458 - $940,435	4,421 New	4,421 $826,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdonald Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcdonald Partners LLC with notifications on news.

Account

Mcdonald Partners LLC Eli Lilly & CO Transaction History